기업 정보 불러오는 중
Just reported
Q3 2026 results
From LifeStance Health's results release of 2026년 11월 5일; its quarterly report has since been filed.
Revenue
Actual
US$455.9M
+25% y/y
+4.7% q/qGuided
US$430M
midpoint
Above guide+6.0%Operating income, GAAP
Actual
US$33.1M
+346% y/y
+7.9% q/qGuided
—
No guide given
Company outlook
Q4 2026
- RevenueUS$446M – US$466M+19% y/y First given
Full year 2026
- RevenueUS$1.741B – US$1.761B+23% y/y Raised +2.7%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes LifeStance Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.US$23.3BA+
EHCEncompass Health CorporationUS$14BA+
ENSGEnsign Group, Inc.US$10.9BA
PACSPACS Group, Inc.US$7.9BA
CONConcentra Group Holdings Parent, Inc.US$5.5BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026년 10월 21일CBGraded C, now B
MCKMckesson Corporation2026년 11월 4일BAGraded B, now A
CVSCVS Health Corp2026년 11월 4일BAGraded B, now A
EWEdwards Lifesciences Corporation2026년 11월 4일BAGraded B, now A
BIIBBiogen Inc.2026년 10월 28일BAGraded B, now A
LifeStance Health Group, Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.
